Monash University’s Precision Medicine research group has discovered multiple new genetic risk factors that make men susceptible to aggressive prostate cancer, in a landmark study [...]
In response to an urgent need for administrative support and workforce training during the COVID-19 pandemic, staff from Victoria’s eight region-based Integrated Cancer Services (ICS) [...]
Essential cancer surgery and screening procedures will continue in Victoria’s public hospitals following the Victorian government’s rapid response to advice from the Victorian COVID-19 Cancer [...]
Preventing further delays in diagnosis and clinical treatment for breast cancer is a top priority for the Victorian COVID-19 Cancer Network’s (VCCN) Breast Cancer Advisory [...]
Victorian health services are concerned about increasing levels of depression and anxiety among healthcare workers due to the pressures created by COVID-19. The situation was [...]
Next month, MPCCC is introducing a new series of online talks presenting innovative and new technologies that are being applied to current cancer and clinical [...]
This May, Monash Partners Comprehensive Cancer Consortium (MPCCC) welcomed Felicity Topp, Chief Executive of Peninsula Health, to the role Governance Group Chair. Ms Topp’s extensive [...]
Delays in routine cancer care due to COVID19 have health professionals on high alert for a variety of service challenges predicted to arise in coming [...]
This month, the ovarian cancer research program at the Hudson Institute of Medical Research, in a collaboration with Monash Health, was awarded $2.2 million from [...]
A new MPCCC partnership with Monash University’s Biomedicine Discovery Institute (Monash BDI) will investigate whether innovative research technologies, including multi-omic and organoid profiling, can improve the [...]
